Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide and the risk of a major cardiovascular event is highest among those with established disease. Ongoing management of these patients relies on the accurate assessment of their response to any prescribed therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, Justine, Zubirán, Rafael, Wolska, Anna, Jialal, Ishwarlal, Remaley, Alan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488498/
https://www.ncbi.nlm.nih.gov/pubmed/37685804
http://dx.doi.org/10.3390/jcm12175737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488498/
https://www.ncbi.nlm.nih.gov/pubmed/37685804
http://dx.doi.org/10.3390/jcm12175737

Ejemplares similares